Shares of Pediapharm Inc. (CVE:PDP – Get Free Report) rose 1.7% during mid-day trading on Thursday . The company traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares traded hands during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Price Performance
The company has a quick ratio of 0.71, a current ratio of 1.12 and a debt-to-equity ratio of 186.87. The stock’s 50-day moving average is C$0.30 and its 200-day moving average is C$0.30. The firm has a market cap of C$66.36 million and a P/E ratio of -4.11.
Pediapharm Company Profile
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Recommended Stories
- Five stocks we like better than Pediapharm
- 5 discounted opportunities for dividend growth investors
- When Is the Best Time to Invest in Mutual Funds?
- 3 Monster Growth Stocks to Buy Now
- Is NVIDIA Stock in a Correction or Consolidation?
- Investing in Travel Stocks Benefits
- 3 Oversold Stocks with Big RSI Rebound Potential
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.